Laboratory selection of Haemonchus contortus for resistance to ivermectin.
The eighth generation of adult Haemonchus contortus, selected by subjecting infected pairs of sheep to suboptimal ivermectin treatment once per generation from parent (P; BBH isolate) through F7 (IV-A; selected isolate), required an approximate 4-fold increase in the ivermectin dose to produce 95% efficacy compared with its contemporary parent isolate. In a dose titration experiment the dose-response curve of the drug pressure-derived isolate, IV-A, was significantly (0.02 less than P less than 0.05) less steep than was the response curve of the parent, BBH, isolate. Potency estimates based upon these nonparallel dose-response curves would not remain constant over a range of efficacy levels but would decrease rapidly at efficacies greater than 95%. Passage of a closed population of the F8 generation of IV-A sequentially through pairs of sheep for an additional 11 generations (F8A-F8K) without additional drug pressure being applied produced no reversion to sensitivity to ivermectin relative to the F7 generation, thus suggesting that the selected "resistance" was stable.
Egerton
J R
JR
Merck Institute for Therapeutic Research, Rahway, New Jersey 07065-0900.
Suhayda
D
D
Eary
C H
CH
D000704:Analysis of Variance; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005243:Feces / Q000469:parasitology; D006188:Haemonchiasis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary; D006189:Haemonchus / Q000187:drug effects*; D007559:Ivermectin / Q000494:pharmacology* / Q000627:therapeutic use; D010270:Parasite Egg Count / Q000662:veterinary; D011897:Random Allocation; D012044:Regression Analysis; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy / Q000469:parasitology; D014251:Trichostrongyloidea / Q000187:drug effects*
D007559:Ivermectin